天然化合物葡萄糖向SGLT2介导的代谢重编程以改善糖尿病病
概括
葡萄糖是一种天然化合物,向-葡萄糖携带体-2 (SGLT2),以逆转代谢功能障碍并减少糖尿病病的纤维化. 这为DKD提供了一种新的治疗方法.
科学领域:
- 肝脏病学
- 代谢疾病
- 药理学
背景情况:
- 糖尿病病 (DKD) 是导致衰竭的主要原因.
- 细胞的代谢重编程导致DKD的纤维化.
- -葡萄糖携带体-2 (SGLT2) 在DKD中加剧了代谢功能障碍.
研究的目的:
- 寻找一种针对SGLT2的天然化合物.
- 验证其在逆转代谢重编程和DKD纤维化的有效性.
主要方法:
- 在SGLT2对4600种天然化合物的选中.
- 在体外验证使用人类管状细胞和在鼠标模型中的体内研究.
- 在SGLT2淘汰和突变模型中评估糖的疗效.
主要成果:
- 在Tyr270中结合SGLT2,促进降解和逆转代谢变化.
- 在实验室中,葡萄糖改善了脂肪酸氧化和线粒体功能.
- 在体内,葡萄糖改善了功能,减少了纤维化,这些影响取决于SGLT2.
结论:
- 葡萄糖是一种新型天然SGLT2破坏剂.
- 它通过纠正管状细胞中的代谢重编程来改善DKD.
- 葡萄糖是一种有前途的DKD治疗策略.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
256
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
256
Glucose Transporters
24.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
Glucose Absorption Into the Small Intestine
32.4K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
32.4K
Secondary Active Transport
7.6K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.6K
Dipeptidyl Peptidase 4 Inhibitors
256
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
256


